April 25th 2025
When it comes to treating multiple myeloma (MM), Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't necessarily guarantee better outcomes.
Dr Farzad Mostashari Explains the New ACO Benchmarking Rule
June 1st 2016The new accountable care organization (ACO) benchmarking rule changes it so ACOs aren't just competing against themselves and transitions so ACOs have to be better than others in their region, Farzad Mostashari, MD, chief executive officer of Aledade, explained at the National Association of ACOs Spring 2016 Conference.
Watch
Dr John Bennett on Slowing Rising Drug Costs
May 31st 2016In order to slow the rising costs of prescription drugs there has to be a greater emphasis on value-based payments, on transparency, and on the consumer, perhaps even with the government’s help, said John Bennett, MD, FACC, FACP, president and CEO of CDPHP.
Watch
Through the Eyes of One ACO: Deciding on Next Generation ACO
May 27th 2016As the most advanced accountable care organization (ACO) model, Next Generation ACO has its appeal. However, it is the riskiest model, and one ACO explains why it decided to stay with the Medicare Shared Savings Program.
Read More
What We're Reading: The Dangers of Not Testing Drugs on Expectant Mothers
May 27th 2016What we're reading, May 27, 2016: treatment for pregnant women is often based on guesswork since few drugs are ever tested on them; a new superbug in the US is resistant to even the antibiotic of last resort; and how small physician practices can adapt to new payment models.
Read More
Dr James Whitfill on Engaging Physicians and Patients in ACOs
May 18th 2016Accountable care organizations have to work more on engaging physicians in meaningful leadership roles and should focus on learning about patient goals, said James Whitfill, MD, chief medical officer of Scottsdale Health Partners.
Watch
Value in Cancer Care: An Economist's Perspective
May 10th 2016Measuring the quality of oncology care and associating it with reimbursement, and high drug prices remain important concerns of value-based outpatient cancer care. A healthcare economist reviews the current status and suggests a potential path forward.
Read More
Dr Farzad Mostashari Explains How ACOs Overcome Short-Term Thinking
May 10th 2016In order for accountable care organizations to overcome short-term thinking they must be careful with their fee-for-service codes and ensure that people are using the system responsibly, Farzad Mostashari, MD, chief executive officer of Aledade, said at the National Association of ACOs Spring 2016 Conference.
Watch
Dr Steven Pearson: Medicare Part B Demonstration Is a Good Learning Opportunity
May 9th 2016The Medicare Part B demonstration has been controversial since its announcement, but Steven D. Pearson, MD, MSc, president of the Institute for Clinical and Economic Review, considers it a wise move on the part of CMS because it provides an opportunity to learn about different payment structures.
Watch